Scynexis (SCYX) Depreciation and Depletion (2013 - 2021)
Scynexis (SCYX) posted Depreciation and Depletion of $67000.0 for Q4 2021, up 39.58% on a QoQ basis from $48000.0 in Q3 2021, and down 43.22% year-over-year from $118000.0 in Q4 2020.
Scynexis (SCYX) Depreciation and Depletion (2013 - 2021) Analysis & Trends
Scynexis' Depreciation and Depletion history runs 9 years deep, the most recent figure standing at $67000.0 for Q4 2021.
- Quarterly Depreciation and Depletion fell 43.22% year-over-year to $67000.0 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $200000.0 (changed 0.0% YoY) and the FY2021 annual result came in at $200000.0, changed 0.0% from the prior year.
- Depreciation and Depletion was $67000.0 for Q4 2021 at Scynexis, up from $48000.0 in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $118000.0 in Q4 2020 and bottomed at $1000.0 in Q1 2017.
- A 5-year average of $30250.0 and a median of $27500.0 in 2020 frame the typical range for Depreciation and Depletion.
- Peak annual rise in Depreciation and Depletion reached 3300.0% in 2018, while the deepest fall reached 97.37% in 2018.
- Scynexis' Depreciation and Depletion stood at $1000.0 in 2017, then surged by 3300.0% to $34000.0 in 2018, then dropped by 23.53% to $26000.0 in 2019, then surged by 353.85% to $118000.0 in 2020, then sank by 43.22% to $67000.0 in 2021.
- Business Quant data shows SCYX's Depreciation and Depletion at $67000.0 in Q4 2021, $48000.0 in Q3 2021, and $58000.0 in Q2 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 36.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 21.60 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 7.20 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 28.00 Mn |
| 10 | Scynexis | 21.55 Mn | -15.20 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 67,000.00 |
| Dec 31, 2021 | 67,000.00 |
| Sep 30, 2021 | 48,000.00 |
| Sep 30, 2021 | 48,000.00 |
| Jun 30, 2021 | 58,000.00 |
| Jun 30, 2021 | 58,000.00 |
| Mar 31, 2021 | 27,000.00 |
| Mar 31, 2021 | 27,000.00 |
| Dec 31, 2020 | 118,000.00 |
| Dec 31, 2020 | 118,000.00 |
| Sep 30, 2020 | 28,000.00 |
| Sep 30, 2020 | 28,000.00 |
| Jun 30, 2020 | 26,000.00 |
| Jun 30, 2020 | 26,000.00 |
| Mar 31, 2020 | 28,000.00 |
| Mar 31, 2020 | 28,000.00 |
| Dec 31, 2019 | 26,000.00 |
| Dec 31, 2019 | 26,000.00 |
| Sep 30, 2019 | 26,000.00 |
| Sep 30, 2019 | 26,000.00 |